UQ Prof Udantha Abeyratne and University team in major breakthrough Source : Dæhæna – Monthly e-Newsletter November 2022 – Queensland Sri Lankans Pfizer has acquired University of Queensland (UQ) startup ResApp Health Limited. ResApp, an ASXlisted company, has developed simple and inexpensive smartphone technology to accurately identify respiratory diseases based on cough analysis. Put it simply, it can diagnose COVID-19 and other respiratory illnesses by listening to someone cough. The technology records a patient’s cough on a smartphone and analyses sounds and simple symptoms, such as a runny nose, to diagnose and measure the severity of a range of chronic and acute diseases, including asthma, pneumonia, bronchiolitis, croup and chronic obstructive pulmonary disease. The UQ technology was developed by (Sri Lankan) Associate Professor Udantha Abeyratne and his UQ team. Dr Abeyratne said that they worked closely with paediatricians and respiratory physicians to develop the diagnostic technology. “When I open up my ...
Blog Archives
Home ⁄ Tag Archives: Pfizer
Pfizer pays $179m for Brisbane company behind smartphone app that claims to diagnose COVID – By Audrey Courty Source : abc A Brisbane-based company that invented a smartphone app it says can diagnose COVID-19 and other respiratory illnesses by listening to someone cough has been purchased by Pfizer for nearly $180 million. ResApp Health Limited uses diagnostic technology developed by Associate Professor Udantha Abeyratne and his research team at the University of Queensland (UQ) to record and analyse a patient’s coughs on a smartphone. The app also considers the self-reporting of simple symptoms like a runny nose or fever to diagnose and measure the severity of a range of pulmonary diseases, including asthma and pneumonia. Pfizer, which is one of the world’s largest bio-pharmaceutical companies, offered to buy ResApp earlier this year when the company announced positive results for its COVID-19 screening test. Recent studies had shown the app had a 92 ...
“VACCINE VARIANTS” – By Des Kelly Call it as you may (Pfizer/Pfizert),while Pfizer “Viagra” is for the “raiser”, for Corona Virus ?, you could do worse than ask for a vaccination bearing the same proud name and reputation. Call it what you will, my preference has always been for this particular Vaccine from the very onset of this Virus, plus all variants of it that may be heading our way from wherever. I rest my case. e’Lanka’s thanks go out to both Keith Bennett and Sunny Perera (altho, even though, his article becomes a little bit “rainy”, sometimes), his name remains Sunny. To all our readers everywhere, please read this, with my compliments. Desmond Kelly (Editor-in-Chief) e’Lanka. An interesting report about the Pfizert Vaccine enough to cause concerns (sent by Sunny Perera ) This is straight from the CEO of Pfizer., Albert Bourla, after generating US$33.5 Billion, this year. ...
Sep 2, 2021
Posted by eLanka admin In
Articles, DESMOND KELLY
Tagged BioNTech, CORONA virus, Moderna, Pfizer, Pfizert, raiser, RNA, Viagra
India approves world’s first DNA Covid vaccine Source:Adaderana India’s drug regulator has approved the world’s first DNA vaccine against Covid-19 for emergency use. The three-dose ZyCoV-D vaccine prevented symptomatic disease in 66% of those vaccinated, according to an interim study quoted by the vaccine maker Cadila Healthcare. The firm plans to make up to 120 million doses of India’s second home-grown vaccine every year. Previous DNA vaccines have worked well in animals but not humans. ...
Aug 30, 2021
Posted by eLanka admin In
elanka Finance
Tagged Cadila Healthcare, DNA Covid vaccine, Dr Jeremy Kamil, Moderna, Pfizer
What is your preferred Jab?-by Dr Harold Gunatillake Transcript: People are confused these days, to choose the vaccine of choice available- Pfizer or AstraZeneca, in Australia. The confusion starts with the publication of the efficacy of the respective vaccines. Pfizer and Moderna had the highest efficacy rates-95% 7 days after the second dose and 94% and 14 days after the second dose respectively. AstraZeneca the vaccine the Australian Government recommends and available for over 60’s is 67%, 15 days after the second dose. Vaccine efficacy rate is calculated after giving the vaccine to 10s and thousands of people and they are broken into two groups. Half of the people get the vaccines, and the other half gets a placebo. After several months they are reviewed. In this trial-170 people were infected with COVID-19. ...
Aug 1, 2021
Posted by eLanka admin In
Articles, Dr harold Gunatillake
Tagged AstraZeneca, COVID-19 cases, Pfizer, Therapeutic Goods Administration
